Venclexta and Hydrocephalus - a phase IV clinical study of FDA data

Summary:

Hydrocephalus is reported only by a few people who take Venclexta.

The phase IV clinical study analyzes which people take Venclexta and have Hydrocephalus. It is created by eHealthMe based on reports of 18,234 people who have side effects while taking Venclexta from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

18,234 people reported to have side effects when taking Venclexta.
Among them, 5 people (0.03%) have Hydrocephalus.


What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 13,671 Venclexta users for its effectiveness, alternative drugs and more.

What is Hydrocephalus?

Hydrocephalus (water on the brain) is found to be associated with 1,709 drugs and 1,149 conditions by eHealthMe.

Number of Venclexta and Hydrocephalus reports submitted per year:

Could Venclexta cause Hydrocephalus?

Time on Venclexta when people have Hydrocephalus *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hydrocephalus when taking Venclexta *:

  • female: 60 %
  • male: 40 %

Age of people who have Hydrocephalus when taking Venclexta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common drugs people take besides Venclexta *:

  1. Glucosamine Sulfate: 1 person, 20.00%
  2. Ditropan Xl: 1 person, 20.00%
  3. Chondroitin Sulfate: 1 person, 20.00%

Common side effects people have besides Hydrocephalus *:

  1. Memory Loss: 2 people, 40.00%
  2. Fall: 2 people, 40.00%
  3. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 20.00%
  4. Urinary Tract Infection: 1 person, 20.00%
  5. Lung Disorder (lung disease): 1 person, 20.00%
  6. Hemiplegia (paralysis of one side of the body): 1 person, 20.00%
  7. Headache (pain in head): 1 person, 20.00%
  8. Head Injury: 1 person, 20.00%
  9. General Symptom: 1 person, 20.00%
  10. Feeling Abnormal: 1 person, 20.00%

Common conditions people have *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 40.00%
  2. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and have Hydrocephalus?

Check whether Hydrocephalus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Hydrocephalus and when was it recovered:

Expand to all the drugs that have ingredients of venetoclax:

Alternative drugs to, pros and cons of Venclexta:

Common Venclexta side effects:

Browse all side effects of Venclexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hydrocephalus treatments and more:

COVID vaccines that are related to Hydrocephalus:

Common drugs associated with Hydrocephalus:

All the drugs that are associated with Hydrocephalus:

Common conditions associated with Hydrocephalus:

All the conditions that are associated with Hydrocephalus:

How the study uses the data?

The study uses data from the FDA. It is based on venetoclax (the active ingredients of Venclexta) and Venclexta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: